首页> 外国专利> Composite biomarker group for lung cancer diagnosis of a subject, lung cancer diagnosis kit using the same, method of using information of composite biomarker group, and computing system for executing the same

Composite biomarker group for lung cancer diagnosis of a subject, lung cancer diagnosis kit using the same, method of using information of composite biomarker group, and computing system for executing the same

机译:用于对象的肺癌诊断的复合生物标记物组,使用该复合生物标记物的肺癌诊断试剂盒,使用复合生物标记物组的信息的方法以及用于执行该复合生物标记物的计算系统

摘要

A method for diagnosing lung cancer in a subject by using a complex biomarker group is provided. The method includes steps of: (a) a computing system (1) acquiring a model M by using expression level data by individual biomarkers in the complex biomarker group and then (2) acquiring expression level data by the individual biomarkers measured from a biological specimen of the subject or their processed data Bk; and (b) the computing system determining whether lung cancer is detected in the subject by using the acquired data of the subject by referring to the model M; wherein the complex biomarker group includes CEA, HE4, ApoA2, TTR, sVCAM-1 and RANTES.
机译:提供了一种通过使用复杂的生物标志物组来诊断受试者的肺癌的方法。该方法包括以下步骤:(a)计算系统(1)通过使用复杂生物标志物组中各个生物标志物的表达水平数据来获取模型M,然后(2)通过从生物样本中测量的各个生物标志物获取表达水平数据受试者或其处理的数据Bk; (b)计算系统通过参照模型M,使用所获取的被检体的数据来判定被检体中是否检测出肺癌。其中所述复杂生物标志物基团包括CEA,HE4,ApoA2,TTR,sVCAM-1和RANTES。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号